1. Home
  2. AMRK vs CRMD Comparison

AMRK vs CRMD Comparison

Compare AMRK & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRK
  • CRMD
  • Stock Information
  • Founded
  • AMRK 1965
  • CRMD 2006
  • Country
  • AMRK United States
  • CRMD United States
  • Employees
  • AMRK N/A
  • CRMD N/A
  • Industry
  • AMRK Other Specialty Stores
  • CRMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMRK Industrials
  • CRMD Health Care
  • Exchange
  • AMRK Nasdaq
  • CRMD Nasdaq
  • Market Cap
  • AMRK 725.9M
  • CRMD 626.8M
  • IPO Year
  • AMRK N/A
  • CRMD 2010
  • Fundamental
  • Price
  • AMRK $29.74
  • CRMD $9.96
  • Analyst Decision
  • AMRK Strong Buy
  • CRMD Strong Buy
  • Analyst Count
  • AMRK 3
  • CRMD 5
  • Target Price
  • AMRK $46.33
  • CRMD $15.20
  • AVG Volume (30 Days)
  • AMRK 374.3K
  • CRMD 1.5M
  • Earning Date
  • AMRK 11-06-2024
  • CRMD 10-30-2024
  • Dividend Yield
  • AMRK 2.69%
  • CRMD N/A
  • EPS Growth
  • AMRK N/A
  • CRMD N/A
  • EPS
  • AMRK 2.44
  • CRMD N/A
  • Revenue
  • AMRK $9,929,517,000.00
  • CRMD $12,262,234.00
  • Revenue This Year
  • AMRK $9.07
  • CRMD N/A
  • Revenue Next Year
  • AMRK $2.32
  • CRMD $277.75
  • P/E Ratio
  • AMRK $12.20
  • CRMD N/A
  • Revenue Growth
  • AMRK 0.59
  • CRMD 41184.20
  • 52 Week Low
  • AMRK $24.22
  • CRMD $2.89
  • 52 Week High
  • AMRK $47.39
  • CRMD $13.85
  • Technical
  • Relative Strength Index (RSI)
  • AMRK 26.57
  • CRMD 44.29
  • Support Level
  • AMRK $28.57
  • CRMD $10.16
  • Resistance Level
  • AMRK $31.64
  • CRMD $11.41
  • Average True Range (ATR)
  • AMRK 1.62
  • CRMD 0.68
  • MACD
  • AMRK -0.08
  • CRMD -0.21
  • Stochastic Oscillator
  • AMRK 12.32
  • CRMD 13.48

About AMRK A-Mark Precious Metals Inc.

A-Mark Precious Metals Inc is a precious metal trading company. It is principally engaged in the wholesale of gold, silver, platinum, copper, and palladium bullion and related products in the form of bars, wafers, coins, and grains. The company's operating segment includes Wholesale Sales and Ancillary Services; Secured Lending and Direct-to-Consumer. It generates maximum revenue from the Wholesale Trading and Ancillary Services segment. The Wholesale Trading and Ancillary Services segment comprises business units such as Industrial, Coin and Bar, Trading and Finance, Storage, Logistics, and Mint. Geographically, it derives a majority of its revenue from the United States and the rest from Europe, Asia Pacific, Australia, Africa, and other regions.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Share on Social Networks: